Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00001160 · ClinicalTrials.gov registry record
Studies on Tumors of the Thyroid
A clinical trial of Thyroid Cancer and Papillary Thyroid Cancer, sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).
- Recruiting
- Registry status
- 2,500
- Enrollment target
- 1
- Study location
NCT00001160: Recruiting study of Thyroid Cancer and Papillary Thyroid Cancer, sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).
NCT00001160 is a study of Thyroid Cancer and Papillary Thyroid Cancer that is actively recruiting participants, run by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). The registered enrollment target is 2,500 participants, above the 227-participant average among 46 other Thyroid Cancer trials with a reported enrollment target (1001% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00001160, a study of Thyroid Cancer and Papillary Thyroid Cancer, is actively recruiting participants, sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).
- RECRUITING
- Registry status
- 2,500 participants
- Enrollment target
- 1
- Study location
Study Summary
Participants in this study will be patients diagnosed with or suspected to have a thyroid nodule or thyroid cancer. The main purpose of this study is to further understand the methods for the diagnosis and treatment of thyroid nodules and thyroid cancer. Many of the test performed are in the context of standard medical care that is offered to all patients with thyroid nodules or thyroid cancer. Other tests are performed for research purposes. In addition, blood and tissue samples will be taken for research and genetic studies....
Primary Outcome
Blood draws, CT and other scans, physical exams, surgery (if applicable), thyroid biopsy (if applicable).
Conditions Studied
Interventions
- DRUG 68-Gallium Dotatate
Study Locations (1)
Maryland
- National Institutes of Health Clinical Center - Bethesda
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,500 participants |
| Start Date | 1977-06-01 |
What NCT00001160 shows while recruiting
NCT00001160 is an observational study that tracks outcomes without assigning an intervention. Its 2,500 participants enrollment target places it among the larger protocols in the corpus, above the 227-participant average among 46 other Thyroid Cancer trials with a reported enrollment target (1001% higher).
The record links to 5 conditions, with Thyroid Cancer appearing as the primary indexed condition, and to 1 intervention - of which 68-Gallium Dotatate is the first listed.
NCT00001160 reports a single indexed study location in Maryland.
Frequently Asked Questions
What is clinical trial NCT00001160 about?
NCT00001160 is a clinical study titled "Studies on Tumors of the Thyroid". Participants in this study will be patients diagnosed with or suspected to have a thyroid nodule or thyroid cancer. The main purpose of this study is to further understand the methods for the diagnosis and treatment of thyroid nodules and thyroid cancer. Many of the test performed are in the contex...
What is the current status of trial NCT00001160?
This trial is currently recruiting. The enrollment target is 2,500 participants. The study started on 1977-06-01.
What conditions does trial NCT00001160 study?
This clinical trial studies the following conditions: Thyroid Cancer, Papillary Thyroid Cancer, Follicular Thyroid Cancer, Hurthle Cell Thyroid Cancer, Tall Cell Variant Thyroid Cancer.
What interventions are being tested in trial NCT00001160?
The interventions under investigation include: 68-Gallium Dotatate (DRUG).
Who is sponsoring clinical trial NCT00001160?
This trial is sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), which has 490 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00001160 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Thyroid Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00001160's enrollment target sits among peer trials
2,500 2nd of 46 the highest of 46 other Thyroid Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Thyroid Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Zanzalintinib for the Treatment of Advanced Thyroid Cancer Before Surgery
RECRUITING · Phase 2
-
Improving Care for Rural Patients With Solid Tumors
RECRUITING · NA
-
A Study to Learn About the Study Medicine Called PF-07799544 as Monotherapy or in Combination in People With Advanced Solid Tumors
RECRUITING · Phase 1
-
Brodalumab in the Treatment of Immune-Related Adverse Events
RECRUITING · Phase 1
-
A Study to Collect Information About the Use of Redifferentiating Medications as a Standard Treatment for Thyroid Cancer
RECRUITING
-
XL092 and Cemiplimab in BRAF WT Thyroid Cancer
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01904188 · 2,500 participants
Clinical Microbial Species & Antibiotic Resistance ID in ED Patients Presenting With Infection - is Rapid ID Possible & Accurate?
- NCT02257229 · 2,500 participants
Prospective Evaluation of Treatment for Clubfoot
- NCT02530658 · 2,500 participants
Next Generation Sequencing of Normal Tissues Prospectively in Pediatric Oncology Patients
- NCT02919280 · 2,500 participants
Dallas 2K: A Natural History Study of Depression
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI